Compatibility Testing in Blood Transfusion - Part 1

Definition: Compatibility testing, previously known as crossmatching, is a series of procedures carried out to ensure a safe transfusion of blood products.
- Objective: To transfuse an appropriate blood product in the safest manner possible while aiming for no adverse transfusion reactions, though reactions cannot be entirely predicted due to individual patient immune system responses.

Maximize patient safety and minimize the risk of adverse events.
Ensure longest possible survival of transfused cells by avoiding transfusion reactions.
Avoid ABO blood group errors and identify clinically significant antibodies that could lead to red cell destruction.

Phases: The process spans from specimen collection to blood component transfusion, which incorporates:
1. Pre-analytical Phase: Involves specimen collection, handling, and processing.
2. Analytical Phase: The actual testing conducted on the blood samples.
3. Post-analytical Phase: Engaging in record-keeping and reviewing results.
Stringent Protocols: Vital to ensure error-free procedures, given that clerical errors are a significant cause of transfusion reactions.

Compatibility testing is routinely performed only for donor products containing red blood cells, not for platelets or plasma.
The testing involves mixing donor red cells with the patient’s serum or plasma to determine compatibility.
- Results Interpretation:
- Compatible: Acceptable for transfusion; no agglutination or hemolysis present.
- Incompatible: Not acceptable for transfusion; necessitates repeating the testing or identifying agglutination or hemolysis-not seen previously.

Primary Reasons for transfusion include:
- Lack of bone marrow production (due to conditions like aplastic anemia).
- Significant blood loss (often due to trauma or conditions like aortic aneurysm).
- Specific clinical situations such as hemoglobinopathies (e.g., Sickle Cell Anemia).
- Notably, hematology-oncology clinics utilize more blood for transfusions than surgical departments.

Requirements for Specimen Collection:
- Ensure accurate patient identification; incorrect identification is a leading cause of transfusion-related fatalities.
- The requisition form must contain patient’s full name and unique identification.
- The requisition should match the patient’s wristband to avoid discrepancies.
Labeling Procedures: Specimens must be labeled at the patient’s bedside with the following details:
- Full name.
- Unique ID number.
- Date of collection.
- Phlebotomist's initials.
Sample Type:
- Preference for non-hemolyzed serum or plasma.
- Plasma is easier to collect and process as it does not require waiting for clotting.

The blood bank will review the patient's history for:
- ABO discrepancies.
- Any history of unexpected antibodies.
- Need for special transfusion requirements.
Handling protocols dictate performing testing as soon as possible to ensure accuracy. Checking labeling before testing is essential.
If blood type history is not available, blood type must be repeated at the facility’s discretion.
Specimens drawn from patients who have been transfused or pregnant within the last three months must be redrawn every three days to minimize the risk of developing new antibodies.

Hospitals must maintain records of all transfusions and patient histories. This includes documenting any antibodies detected during pre-transfusion testing.
In case of an unexpected transfusion reaction, patient samples and donor segments are retained for at least seven days for potential testing and investigation.

Careful attention to detail in compatibility testing and maintaining stringent protocols around specimen handling, testing, and patient identification is paramount in minimizing errors and ensuring patient safety in blood transfusion practices.